The role of hepatitis C virus genotypes and core mutations in hepatocellular carcinoma in Cameroon

Background Hepatitis C virus (HCV) infection is known to be an important risk factor for hepatocellular carcinoma (HCC) in Cameroon. However, the effect of HCV‐related factors on HCC development still remains unknown in the Central Africa. In this study, we investigated the role of HCV genotypes and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of viral hepatitis 2020-09, Vol.27 (9), p.880-885
Hauptverfasser: Amougou‐Atsama, Marie, Jean Adrien Atangana, Paul, Noah Noah, Dominique, Fewou Moundipa, Paul, Pineau, Pascal, Njouom, Richard
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Hepatitis C virus (HCV) infection is known to be an important risk factor for hepatocellular carcinoma (HCC) in Cameroon. However, the effect of HCV‐related factors on HCC development still remains unknown in the Central Africa. In this study, we investigated the role of HCV genotypes and core mutations in HCC development in Cameroonian patients. Methods A case‐control study was conducted using patients with HCV‐related HCC and matched controls individuals with chronic HCV infection but without HCC. HCV genotypes and mutations were determined using a hemi‐nested amplification and sequencing analysis focus on the core and NS5B HCV regions. Results We identify HCV genotype 1, 2 and 4 in both groups. Interestingly, genotype 4 was significantly more prevalent in HCC patients (53.3%). Overall, distribution of genotypes was very different between cases and controls (P = 4.2 E‐7). The risk factors analysis showed that infection with HCV‐4 is strongly associated with HCC development with odd ratio, 95% confidence interval and p‐values of 7.4 (95% CI: 2.08‐26.6; P = .001). Furthermore, the risk of developing HCC increased even more significantly in case of infection with HCV subtype 4f with the odd ratio of 20.8 (95% CI, 4.1‐66.8; P 
ISSN:1352-0504
1365-2893
DOI:10.1111/jvh.13303